Kiniksa Pharmaceuticals, Ltd.
NASDAQ:KNSA
22.16 (USD) • At close March 13, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||
| Net Income
| -43.193 | 14.084 | 183.363 | -157.924 | -161.381 | -161.867 | -103.227 | -64.873 | -23.973 |
| Depreciation & Amortization
| 1.695 | 2.341 | 2.402 | 2.355 | 2.405 | 2.068 | 0.286 | 0.028 | 0.022 |
| Deferred Income Tax
| 8.132 | -33.788 | -185.495 | 0.011 | 4.361 | -3.156 | -0.978 | -0.197 | -0.046 |
| Stock Based Compensation
| 30.693 | 27.149 | 25.12 | 25.173 | 20.875 | 15.08 | 5.701 | 0.897 | 0.368 |
| Change In Working Capital
| 24.809 | 1.35 | -22.575 | 0.689 | -4.315 | -17.025 | 18.328 | 13.926 | 1.762 |
| Accounts Receivables
| -20.458 | -0.95 | -8.675 | -3.91 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 4.758 | -9.523 | -17.924 | -3.675 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| -6.306 | 0.347 | 6.031 | 1.366 | -4.969 | -4.705 | 8.823 | 1.006 | 0.119 |
| Other Working Capital
| 46.815 | 11.476 | -2.007 | 6.908 | 0.654 | -12.32 | 9.505 | 12.92 | 1.643 |
| Other Non Cash Items
| 3.553 | 2.165 | 2.992 | 3.398 | 1.523 | 6.531 | -1.122 | -0.053 | 0.293 |
| Operating Cash Flow
| 25.689 | 13.301 | 5.807 | -126.298 | -136.532 | -158.369 | -81.012 | -50.219 | -21.867 |
| Investing Activities: | |||||||||
| Investments In Property Plant And Equipment
| -0.277 | -0.13 | -0.105 | -20.415 | -0.283 | -3.203 | -5.29 | -0.069 | -0.003 |
| Acquisitions Net
| 0 | 0 | 0.091 | 20 | 23.161 | -52.417 | 0 | 0 | 0 |
| Purchases Of Investments
| -202.014 | -204.933 | -135.864 | -157.25 | -430.211 | -488.773 | -402.008 | 0 | 0 |
| Sales Maturities Of Investments
| 239.938 | 175.506 | 127.8 | 306.3 | 407.05 | 541.19 | 168.1 | 0 | 0 |
| Other Investing Activites
| 0.025 | 0 | -7.973 | -20 | -23.161 | 52.417 | -233.908 | 0 | 0 |
| Investing Cash Flow
| 37.672 | -29.557 | -8.078 | 128.635 | -23.444 | 49.214 | -239.198 | -0.069 | -0.003 |
| Financing Activities: | |||||||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 0 | 0 | 3.417 | 5.885 | 228.222 | 83.106 | 159.194 | 39.873 | 42.509 |
| Common Stock Repurchased
| -4.984 | -2.206 | -0.901 | 5.885 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 17.25 | 3.701 | 3.417 | 5.885 | -1.136 | 1.001 | 187.542 | 39.873 | 42.509 |
| Financing Cash Flow
| 12.266 | 1.495 | 2.516 | 5.885 | 227.086 | 84.107 | 346.736 | 39.873 | 42.509 |
| Other Information: | |||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| 75.627 | -14.761 | 0.245 | 8.222 | 67.11 | -25.048 | 26.526 | -10.415 | 20.639 |
| Cash At End Of Period
| 183.581 | 107.954 | 122.715 | 122.47 | 114.248 | 47.138 | 72.186 | 45.66 | 56.075 |